Financial Performance - The company revised its 2024 net profit forecast to a loss of CNY 484.93 million, compared to the previous estimate of a loss between CNY 200 million and CNY 290 million[2]. - The net profit attributable to shareholders for 2023 was a loss of CNY 531.60 million, with a loss of CNY 516.14 million after deducting non-recurring gains and losses[4]. - The company reported a basic earnings per share of CNY -0.76 for the year 2023[4]. Impairment Losses - The company adjusted its credit impairment loss provision by approximately CNY 76 million based on a cautious assessment of the recoverability of receivables[5]. - An additional adjustment of approximately CNY 115 million was made for asset impairment losses related to the progress status of construction projects[5]. Communication and Forecasting - The company expressed sincere apologies to investors for the inconvenience caused by the performance forecast correction[7]. - The company emphasized the importance of improving communication with auditing firms to enhance the timeliness and accuracy of performance forecasts[7]. - The revised forecast data has been audited by the accounting firm, and there are no significant discrepancies between the company and the auditors regarding the revised data[6]. - The performance forecast correction was primarily due to the short preparation time and the ongoing annual audit process[5]. - The company aims to avoid similar situations in the future by strengthening its judgment on factors affecting performance forecasts[7].

Financial Performance - The net profit attributable to shareholders of the parent company for 2024 was -116,957,614.78 CNY, showing an improvement from -129,135,920.26 CNY in 2023[4]. - Total revenue for 2024 was 202,401,950.89 CNY, a slight increase of 2.09% compared to 198,255,380.71 CNY in 2023[19]. - The net cash flow from operating activities for 2024 was -37,585,111.66 CNY, worsening from -31,808,486.67 CNY in 2023[19]. - The total assets decreased by 9.65% to 587,276,757.11 CNY at the end of 2024, down from 649,997,807.25 CNY in 2023[19]. - The net assets attributable to shareholders of the parent company decreased by 31.05% to 259,721,007.32 CNY at the end of 2024, compared to 376,678,622.10 CNY in 2023[19]. - Basic earnings per share for 2024 were -0.45 CNY, slightly improved from -0.49 CNY in 2023[20]. - The company reported a net loss of CNY 249,830,725.66 in 2024, compared to a net loss of CNY 84,142,271.84 in 2023, indicating a worsening of approximately 196.67%[194]. - The total profit for 2024 was CNY -168,376,568.16, compared to CNY -81,739,633.04 in the previous year, reflecting a negative trend[199]. Revenue and Sales - The company reported a decrease in revenue from main business activities, with a total of 190,630,964.41 CNY in 2024, up 5.38% from 180,903,862.74 CNY in 2023[19]. - The company achieved operating revenue of 202.40 million RMB, a year-on-year increase of 2.09%[26]. - The company's total revenue for the home furnishing sector reached ¥194,060,153.25, representing a year-on-year increase of 3.69%[67]. - The revenue from the high-end custom furniture segment was ¥79,658,177.02, with a gross profit margin of 42.31%, showing a slight decrease of 0.23% compared to last year[68]. - The revenue from the cabinet category decreased by 22.72% year-on-year, while the bed group category saw a decline of 19.56%[67]. - The direct sales model generated ¥72,255,809.45 in revenue, with a gross profit margin of 41.88%, despite a year-on-year decline of 16.12%[68]. Expenses and Costs - Sales and management expenses decreased by 21.73% compared to the same period last year, but the expense ratios remained high due to revenue pressure[26]. - Research and development expenses decreased by 28.44% to CNY 7.85 million compared to the previous year[63]. - Total operating costs decreased to CNY 280,869,463.66 in 2024 from CNY 315,834,897.04 in 2023, representing a reduction of about 11.06%[196]. - The sales expenses decreased by 19.66% to 70,861,300.58 compared to the previous year, primarily due to reduced renovation and rental costs[75]. Assets and Liabilities - The company's total equity decreased to CNY 343,541,506.48 in 2024 from CNY 509,229,960.30 in 2023, reflecting a decline of about 32.54%[194]. - The total current assets amount to RMB 228.30 million, an increase from RMB 214.57 million in the previous year, indicating a growth of approximately 6.93%[189]. - The total non-current assets decreased to CNY 261.12 million from CNY 298.65 million, indicating a decline of about 12.59%[189]. - The total liabilities increased to CNY 166,210,008.80 in 2024 from CNY 122,575,113.23 in 2023, marking an increase of approximately 35.52%[194]. Corporate Governance - The company has established a complete corporate governance structure in compliance with relevant laws and regulations[107]. - The company held a total of 3 shareholder meetings and 9 board meetings during the reporting period[107]. - The total remuneration for all directors, supervisors, and senior management was 3.3284 million yuan[114]. - The company has not faced any regulatory requirements for rectification during the reporting period[107]. - The company’s board of directors and supervisory board operated independently without any issues[107]. Strategic Initiatives - The company is actively expanding its mid-range furniture production line to provide comprehensive home living solutions[26]. - The company implemented a dual strategy of "distribution network optimization + digital marketing innovation" to enhance its market ecosystem, focusing on standardized sales empowerment and dynamic evaluation mechanisms[27]. - The company is advancing its digital transformation with a focus on "smart manufacturing + precise service," optimizing production lines and enhancing supply chain efficiency[27]. - The company aims to enhance its brand image and market position by expanding its product series and maintaining a high-quality positioning for its main brand A-ZENITH[54]. Risks and Challenges - The company has outlined potential risks in its future development, which investors should be aware of[5]. - The company is facing a delisting risk due to a negative net profit and revenue below 300 million CNY for the fiscal year 2024[147]. - The company faces risks related to new product development, including potential misalignment with market demands, which could affect sales performance[102]. - The company operates under a "direct sales + distribution" model, which may face challenges if distributors experience sales slowdowns or operational issues[104]. Environmental and Social Responsibility - The company invested 192,000 CNY in environmental protection during the reporting period[137]. - The company implemented carbon reduction measures, resulting in a decrease of 253.7 tons of CO2 emissions through the use of solar power[140]. - The company emphasizes training programs aimed at enhancing professional skills and innovation awareness among employees[128].

上海城地香江数据科技股份有限公司2025 年第一季度报告 证券代码：603887 证券简称：城地香江 上海城地香江数据科技股份有限公司 2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | | | | 本报告期比上年同 | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 | 期增减变动幅度 | | | | | (%) | | 营业收入 | 419,885,418.70 | 243,476,890.88 | 72.45 | | 归属于上市公司股东的净利 润 | 18,224,649.74 ...

Financial Performance - The company's operating revenue for Q1 2025 reached ¥117,238,079.29, a significant increase of 191.96% compared to ¥40,155,592.72 in the same period last year[4] - The net profit attributable to shareholders was ¥3,855,617.40, a turnaround from a loss of ¥11,627,143.68 in the previous year[4] - The basic earnings per share for the period was ¥0.0101, compared to a loss of ¥0.0305 per share in the same period last year[4] - Total operating revenue for Q1 2025 reached ¥117,238,079.29, a significant increase of 192.4% compared to ¥40,155,592.72 in Q1 2024[19] - Net profit for Q1 2025 was ¥3,856,995.12, a turnaround from a net loss of ¥11,627,143.68 in Q1 2024[20] - Earnings per share for Q1 2025 was ¥0.0101, compared to a loss per share of ¥0.0305 in Q1 2024[21] - The company reported a total profit of ¥4,299,850.91 for Q1 2025, compared to a total loss of ¥13,232,580.36 in Q1 2024[20] Cash Flow - The net cash flow from operating activities was -¥67,983,322.71, a decrease of 261.59% from ¥42,072,007.28 in the previous year[4] - Cash received from sales and services in Q1 2025 was ¥163,885,048.15, down 20.3% from ¥205,566,520.24 in Q1 2024[24] - The total cash outflow from operating activities was $240,218,525.21, compared to $199,421,729.67 previously[25] - Cash outflow for investment activities was $22,151,222.09, significantly higher than $1,700,841.70 in the previous period[25] - The net cash flow from investment activities was -$12,151,222.09, compared to -$1,700,841.70 previously[25] - The cash flow from operating activities showed a significant decline, indicating potential operational challenges[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,649,654,490.94, a decrease of 1.99% from ¥1,683,168,504.70 at the end of the previous year[5] - Current assets total CNY 1,182,534,825.63, down from CNY 1,214,077,946.52 in the previous period[13] - Total liabilities stand at CNY 1,412,433,367.44, down from CNY 1,451,385,501.86, showing a reduction of approximately 2.7%[15] - Current liabilities total CNY 1,341,771,128.86, a decrease from CNY 1,399,159,310.78, indicating a decline of about 4.1%[15] - Non-current assets amount to CNY 467,119,665.31, slightly down from CNY 469,090,558.18[14] - The company’s total liabilities and equity reached ¥1,649,654,490.94, reflecting a decrease in equity compared to the previous year[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 30,181[9] - Beijing Hanjian Group holds 133,697,200 shares, accounting for 34.17% of total shares, with 114,872,200 shares pledged and 12,385,000 shares judicially frozen[10] Government Subsidies and Projects - The increase in operating revenue was primarily due to the normal production and supply of the Anhui PCCP project[7] - The company reported a government subsidy of ¥78,083.33, which is expected to have a continuous impact on its profits[6] - The company is focused on the normal settlement of the Anhui PCCP project, which has positively influenced its profit totals[7] Other Financial Metrics - The weighted average return on equity increased by 4.40 percentage points to 1.65% from -2.75% in the previous year[4] - Research and development expenses for Q1 2025 were ¥714,653.76, a decrease of 48.9% from ¥1,371,983.80 in Q1 2024[20] - Other comprehensive income for Q1 2025 was ¥310,578.66, recovering from a loss of ¥462,058.72 in Q1 2024[21] - The company reported a cash balance of CNY 69,804,438.33, a decrease from CNY 112,107,087.17[13] - The company has a long-term investment of CNY 24,576,906.90, down from CNY 26,176,021.85[14]

江苏南方卫材医药股份有限公司2025 年第一季度报告 证券代码：603880 证券简称：南卫股份 江苏南方卫材医药股份有限公司 2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人李平、主管会计工作负责人项琴华及会计机构负责人（会计主管人员）王亚华保证季 度报告中财务信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 上年同期 | 本报告期比上年同 期增减变动幅度(%) | | --- | --- | --- | --- | | 营业收入 | 170,922,078.18 | 139,180,514.20 | 22.81 | | 归属于上市公司股东的净利润 | -7,917,932.55 | 1,745,086.17 | ...

Financial Performance - The net profit attributable to shareholders for 2024 is -483,930,115.11 yuan, resulting in no profit distribution or capital reserve transfer for the year[5]. - The company's operating revenue for 2024 was CNY 1,361,939,088.52, a decrease of 28.53% compared to CNY 1,905,697,448.75 in 2023[22]. - The net profit attributable to shareholders for 2024 was CNY -483,930,115.11, showing an improvement of 8.97% from CNY -531,600,953.89 in 2023[22]. - The total assets at the end of 2024 were CNY 7,297,077,180.76, down 11.31% from CNY 8,227,893,085.72 in 2023[22]. - The net cash flow from operating activities for 2024 was CNY -439,715,908.28, a decline of 48.16% compared to CNY -296,792,997.60 in 2023[22]. - The net assets attributable to shareholders decreased by 61.50% to CNY 374,692,714.27 at the end of 2024 from CNY 973,137,119.15 in 2023[22]. - The company reported a decrease in revenue from core business activities, with a total of CNY 1,345,792,080.34 in 2024, down 27.71% from CNY 1,861,579,342.26 in 2023[22]. - The company reported a total revenue of 136,193.91 million yuan for 2024, a decrease of 28.53% compared to the same period last year[23]. - The net profit attributable to shareholders was -48,393.01 million yuan, an increase of 4,767.08 million yuan year-on-year, mainly due to a reduction in bad debt provisions and increased investment income[23]. - Basic and diluted earnings per share for 2024 were -0.69 yuan, improving by 9.21% from -0.76 yuan in 2023[23]. - The weighted average return on equity decreased to -66.82%, down 25.69 percentage points from -41.13% in the previous year[23]. Audit and Compliance - The company received an audit report with a disclaimer of opinion from Dahua Accounting Firm, indicating significant concerns regarding financial reporting[4]. - The internal control audit report issued by Dahua Accounting Firm indicated that the company failed to maintain effective internal controls over financial reporting as of December 31, 2024[135]. - The company received an administrative penalty from the China Securities Regulatory Commission on March 29, 2024, related to regulatory compliance issues[113]. - The company is facing delisting risk due to an audit report with a disclaimer of opinion and a negative internal control audit report issued by Dahua Certified Public Accountants[156]. Strategic Planning and Development - The company plans to maintain stable operations and consider future development needs in its strategic planning[5]. - The management provided a cautious outlook for the upcoming fiscal year, emphasizing the need for strategic adjustments in response to market conditions[22]. - The company is focusing on expanding its market presence and exploring new strategies for growth[22]. - The company is actively involved in the development of new products and technologies to enhance its service offerings[22]. - The company has plans for potential mergers and acquisitions to strengthen its market position[22]. - The company aims to maintain the momentum in the cultural tourism and non-ferrous metal mining sectors while fully advancing its infrastructure construction towards new energy and intelligent computing services[90]. - The company plans to accelerate the implementation of new intelligent computing services, striving for early profitability[91]. - The company expects to complete water conservancy investments of 40 billion yuan in 2025, focusing on the construction of major water source projects and pipeline networks exceeding 10,000 kilometers[87]. - The company is actively expanding into the new energy sector, with plans to develop large-scale wind and solar projects, aiming for over 50 million kilowatts of clean energy capacity by 2025[88]. Risk Management - There are indications of non-operational fund occupation by controlling shareholders and related parties[7]. - The report includes a forward-looking statement risk disclaimer, cautioning investors about potential uncertainties[6]. - The company faces risks from macroeconomic fluctuations, which could impact its performance due to the cyclical nature of infrastructure investments[92]. - The company is committed to enhancing operational efficiency in the cultural tourism sector to ensure steady growth[91]. - The company aims to strengthen internal controls and improve compliance awareness among employees to mitigate risks and promote sustainable development[158]. Corporate Governance - The board of directors and supervisory board have confirmed the authenticity and completeness of the annual report, with all directors present at the meeting[3]. - The company has implemented a robust corporate governance structure, including a board of directors, supervisory board, and various committees to ensure effective oversight and decision-making[97]. - The company has established a comprehensive internal control system for human resources management, covering recruitment, training, compensation, and employee discipline[99]. - The company has a dedicated internal audit department that conducts comprehensive audits of its operations and internal control systems[98]. - The company has received commitments from its controlling shareholders to avoid any competition with its business operations[102]. Shareholder Information - The company will not distribute profits for the fiscal year 2023 as per the board's resolution on April 29, 2024[115]. - The total remuneration for directors and senior management during the reporting period amounted to 552.67 million yuan[105]. - The total number of employees in the parent company and major subsidiaries is 955, with 558 being technical personnel[124]. - The company organized 12 training sessions in 2024, with over 280 participants, aimed at enhancing employee skills[127]. - The company has a total of 14 employees with a postgraduate degree or higher, and 390 employees with a bachelor's degree[125]. Environmental and Social Responsibility - The company has established environmental protection mechanisms and has not faced any administrative penalties related to environmental issues during the reporting period[139]. - The company has taken steps to reduce carbon emissions, including energy management and pollution prevention measures[143]. - The company has not published a separate social responsibility or ESG report during the reporting period[144]. Legal and Financial Issues - The company has a total of 3,500 million RMB in illegal guarantees, representing 9.34% of net assets[153]. - The company has provided guarantees to other companies, but sufficient audit evidence regarding the completeness of these guarantees could not be obtained[200]. - There are multiple lawsuits and arbitration cases due to overdue debts, raising concerns about the company's ability to continue as a going concern[198]. - The management has disclosed plans and measures to improve going concern capability, but their implementation remains highly uncertain[198].

证券代码：603500 证券简称：祥和实业 浙江天台祥和实业股份有限公司 2025 年第一季度报告 浙江天台祥和实业股份有限公司2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 1 / 16 单位：元 币种：人民币 项目 本报告期 上年同期 本报告期比上 年同期增减变 动幅度(%) 调整前 调整后 调整后 营业收入 189,340,075.85 156,049,009.15 156,049,009.15 21.33 归属于上市公司股东 的净利润 35,449,543.21 18,379,812.22 18,379,812.22 92.87 归属于上 ...

江苏振江新能源装备股份有限公司2025 年第一季度报告 证券代码：603507 证券简称：振江股份 江苏振江新能源装备股份有限公司 2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 上年同期 | 本报告期比上年同期增 | | --- | --- | --- | --- | | | | | 减变动幅度(%) | | 营业收入 | 937,007,852.83 | 998,567,669.33 | -6.16 | | 归属于上市公司股东的净 利润 | 7,194,528.12 | 63,325,205.83 | -88.64 | | 归属于上市公司股东的扣 除非经常性损益的净利润 | 35,363,464.88 | 65,492,133.18 | -46.00 | ...

Financial Performance - The company's total revenue for 2024 was CNY 602,615,333.02, a slight increase of 0.42% compared to CNY 600,095,343.68 in 2023[24]. - The net profit attributable to shareholders for 2024 was a loss of CNY 190,668,979.26, representing a decline of 29.34% from a loss of CNY 147,417,266.38 in 2023[24]. - The basic earnings per share for 2024 was -CNY 0.66, a decrease of 29.41% from -CNY 0.51 in 2023[25]. - The net profit attributable to shareholders of the parent company was CNY -190.67 million, a decrease of CNY 43.25 million year-on-year[33]. - The company achieved operating revenue of CNY 602.62 million in 2024, an increase of CNY 2.52 million compared to the same period last year[33]. - Operating costs rose to 616.73 million yuan, reflecting a 13.28% increase due to higher sales volume[57]. - The company reported a net profit of -31.82 million RMB for its subsidiary, Southern Meibang, indicating ongoing financial challenges[98]. Cash Flow and Assets - The net cash flow from operating activities increased significantly to CNY 63,320,497.91, up 308.27% from CNY 15,509,532.60 in the previous year[24]. - The company's total assets decreased by 17.28% to CNY 1,056,553,004.60 at the end of 2024, down from CNY 1,277,326,306.30 in 2023[24]. - The net assets attributable to shareholders fell by 40.48% to CNY 279,286,644.13, compared to CNY 469,268,077.30 at the end of 2023[24]. - The company reported a net cash flow from operating activities of CNY 56.82 million in the fourth quarter[28]. Market and Competition - The decline in net profit was attributed to increased market competition, price drops, and rising raw material costs for nitrile gloves[26]. - The company reported that product sales volume increased, but overall revenue was affected by price fluctuations in the industry[26]. - The traditional medical consumables market is expected to exceed CNY 220 billion by 2025, driven by national policies and increasing demand[35]. - The traditional medical supplies market is projected to exceed 220 billion RMB, driven by a 15% annual increase in demand for emergency equipment[37]. - The export value of medical supplies is anticipated to reach 80 billion RMB in 2025, reflecting a 15% year-on-year growth[37]. Research and Development - Research and development expenses amounted to CNY 28.72 million, representing a 1.92% increase from the previous year, focusing on transdermal drug delivery technology and process upgrades[34]. - The company holds 16 invention patents, 73 utility models, and 9 design patents, enhancing its competitive edge in technology development[34]. - The company established a new R&D center in collaboration with Zhejiang University, focusing on transdermal drug delivery technologies[50]. - The company is focusing on R&D, production, and sales of transdermal products, medical adhesive tapes, emergency kits, and protective supplies[38]. Operational Efficiency - The company has effectively reduced operational risks and improved internal control management during the reporting period[33]. - The company is focused on optimizing production management to enhance core competitiveness and reduce costs[34]. - The company employs an "order-based" production model, ensuring production aligns with customer demand[46]. - The company emphasizes technological R&D, continuously upgrading equipment and processes to maintain competitive advantages[49]. Governance and Management - The management team has extensive experience and has established a standardized management system covering all operational aspects[52]. - The company has a diverse board of directors with expertise in law, finance, and management[128]. - The overall management structure supports the company's long-term growth strategy[128]. - The company plans to optimize its governance structure and improve internal control management systems to ensure compliance and efficiency[104]. Shareholder and Investor Relations - The company plans to apply for comprehensive credit facilities from banks and other financial institutions for the year 2024[125]. - The company has a cash dividend policy that mandates a minimum of 25% of distributable profits to be distributed as cash dividends when conditions allow[151]. - The company did not propose any cash profit distribution plan despite having a positive profit available for distribution to shareholders, and it must disclose the reasons and usage plans for undistributed profits[155]. - The company emphasizes investor relations and maintains transparent communication with stakeholders to protect their interests and enhance sustainable development[122]. Environmental and Social Responsibility - The company invested 1.52 million RMB in environmental protection during the reporting period[162]. - The company has not faced any administrative penalties due to environmental issues during the reporting period[164]. - The company adheres to national environmental laws and regulations, actively managing environmental facilities and emissions[166]. - There are no separate disclosures for social responsibility or sustainability reports during the reporting period[168]. Legal and Compliance Issues - The company received a notice from the China Securities Regulatory Commission regarding suspected violations of information disclosure laws[182]. - The company has reported a 20% decrease in audit fees compared to the previous year[177]. - The company is involved in significant litigation matters, including disputes with Beijing Sentai Weiye International Trade Co., with a claim amount of 487.10 million RMB[180]. - The company has made provisions for bad debts amounting to 459.31 million RMB related to the litigation with Beijing Sentai Weiye International Trade Co.[180]. Future Outlook and Strategy - The company aims to enhance the profitability of its main products and control production costs and expenses by 2025[102]. - The company is actively pursuing market expansion through the development of new medical products and technologies, aiming to enhance its competitive position in the industry[93]. - The company plans to explore the development of more emergency series products for various fields, including family, traffic accidents, and natural disasters[85]. - The company is considering strategic acquisitions to bolster its product portfolio, with a budget of 100 million allocated for potential deals[130].

正平路桥建设股份有限公司2025 年第一季度报告 证券代码：603843 证券简称：正平股份 正平路桥建设股份有限公司 2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | | | | 本报告期比上年 | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 | 同期增减变动幅 | | | | | 度(%) | | 营业收入 | 146,974,287.30 | 238,161,929.10 | -38.29 | | 归属于上市公司股东的净 利润 | 14,571,522.99 | -16, ...